secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001193125-26-039365
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Carole Ho resigns from Beam Therapeutics board effective Feb 27, 2026
------------------------------------------------------------------------------

- Carole Ho notified resignation on Jan 31, 2026, effective Feb 27, 2026.
- Resignation not due to any disagreement with Beam on operations, policies, or practices.
- No successor or replacement director announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526039365/0001193125-26-039365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526039365/beam-20260131.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-039365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer